FOLH1 and central nervous system cancer: Recently, Liu et al. published a report from 30 glioma patients, in which they demonstrated PSMA expression on IHC staining in zero out of 14 grade II gliomas, two out of four grade III gliomas, and nine out of 12 GBMs [24].